Index of reports
> Life Threatening Events (34)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Neupogen (Filgrastim) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 34 Next >>
Possible Neupogen side effects in 45 year old female
Reported by a physician from India on 2012-07-20
Patient: 45 year old female
Reactions: Thrombocytosis, Deep Vein Thrombosis
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Neupogen
Other drugs received by patient: Aripiprazole
Possible Neupogen side effects in 58 year old male
Reported by a physician from Czech Republic on 2012-06-14
Patient: 58 year old male
Reactions: Acute Myeloid Leukaemia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Neupogen
Possible Neupogen side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-28
Patient: male
Reactions: Foetal Distress Syndrome, Premature Delivery
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Etoposide
Indication: Neuroblastoma
Neupogen
Indication: Neuroblastoma
Cisplatin
Indication: Neuroblastoma
Possible Neupogen side effects in 71 year old male
Reported by a physician from Japan on 2012-05-10
Patient: 71 year old male
Reactions: White Blood Cell Count Decreased, Interstitial Lung Disease, Anaemia, Platelet Count Decreased, Pleural Effusion
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Sprycel
Dosage: 70 mg, 2x/day
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-02-22
Neupogen
Indication: Acute Lymphocytic Leukaemia
Oncovin
Indication: Acute Lymphocytic Leukaemia
Idarubicin HCL
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-02-08
End date: 2012-02-15
Cytarabine
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-02-08
End date: 2012-02-15
Other drugs received by patient: Candesartan Cilexetil; Dexamethasone Sodium Phosphate; Fluconazole; Allopurinol; Polymyxin B Sulfate; Cotrim; Neutrogin
Possible Neupogen side effects in 46 year old female
Reported by a physician from Brazil on 2012-05-01
Patient: 46 year old female, weighing 55.0 kg (121.0 pounds)
Reactions: Agranulocytosis, Diabetes Mellitus, Hypothyroidism, Diabetic Ketoacidosis
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Pegasys
Dosage: 180 mug, qwk
Indication: Hepatitis C
Start date: 2011-04-28
End date: 2012-02-16
Neupogen
Dosage: unk, qwk
Indication: Agranulocytosis
Start date: 2011-06-02
End date: 2012-02-19
Other drugs received by patient: Ribavirin
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-24
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: White Blood Cell Count Decreased, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Prednisolone
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Administration route: Oral
Indication: Schizophrenia
Start date: 2011-12-02
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Neupogen
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Clozapine
Administration route: Oral
Start date: 2010-09-15
End date: 2011-12-01
Other drugs received by patient: Citalopram Hydrobromide; Pirenzepine; Amisulpride
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-04-03
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: White Blood Cell Count Decreased, Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Vincristine Sulfate
Dosage: 2 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Doxorubicin HCL
Dosage: 110 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Prednisolone
Dosage: 60 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Neupogen
Dosage: 800 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Start date: 2011-12-02
Cyclophosphamide
Dosage: 1600 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Other drugs received by patient: Pirenzepine; Amisulpride; Citalopram
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-30
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: White Blood Cell Count Decreased, Agranulocytosis, Sepsis, Neutropenia, Deep Vein Thrombosis, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 110 mg milligram(s),intravenous (not otherwise specified)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Cyclophosphamide
Dosage: 1600 mg milligram(s)intravenous (not otherwise specified)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Neupogen
Dosage: 800 mg milligram(s)intravenous (not otherwise specified)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Vincristine Sulfate
Dosage: 2 mg milligram(s), intravenous (not otherwise specified)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Prednisolone
Dosage: 60 mg milligram(s)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg milligram(s) ( 1 day ) oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Clozapine
Dosage: 200 mg milligram(s) ( 1 day ) oral
Indication: Schizophrenia
Start date: 2011-12-02
Other drugs received by patient: Citalopram Hydrobromide
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-27
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: White Blood Cell Count Decreased, Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1600 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Prednisolone
Dosage: 60 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Vincristine Sulfate
Dosage: 2 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Doxorubicin HCL
Dosage: 110 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Start date: 2011-12-02
Neupogen
Dosage: 800 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Other drugs received by patient: Amisulpride; Pirenzepine; Citalopram
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-20
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutrophil Count Increased, Neutropenia, Deep Vein Thrombosis, White Blood Cell Count Increased, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Prednisolone
Dosage: 60 mg mgilligram(s), intravenous
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Neupogen
Dosage: 800 mg milligram(s), intravenous
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Vincristine Sulfate
Dosage: 2 mg milligram(s), intravenous
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Cyclophosphamide
Dosage: 1600 mgilligram(s), intravenous
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Doxorubicin HCL
Dosage: 110 mg milligram(s), intravenous
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg mgilligram(s), 1 day, oral
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Other drugs received by patient: Citalopram Hydrobromide; (Amisulpride); (Pirenzepine)
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-15
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: Diffuse Large B-Cell Lymphoma Stage II, White Blood Cell Count Decreased, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1600 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Doxorubicin HCL
Dosage: 110 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Neupogen
Dosage: 800 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Start date: 2011-12-02
Vincristine Sulfate
Dosage: 2 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Prednisolone
Dosage: 60 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Other drugs received by patient: Amisulpride; Pirenzepine; Citalopram
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-12
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: White Blood Cell Count Decreased, Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Deep Vein Thrombosis, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Cyclophosphamide
Dosage: 1600 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Prednisolone
Dosage: 60 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Vincristine Sulfate
Dosage: 2 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Doxorubicin HCL
Dosage: 110 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Neupogen
Dosage: 800 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Start date: 2011-12-02
Other drugs received by patient: Citalopram; Amisulpride; Pirenzepine
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-09
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: Agranulocytosis, Blood Disorder, Neutropenia, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1600 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Prednisolone
Dosage: 60 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, bid
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Neupogen
Dosage: 800 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, bid
Administration route: Oral
Start date: 2011-12-02
Doxorubicin HCL
Dosage: 110 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Other drugs received by patient: Citalopram Hydrobromide; Pirenzepine; Amisulpride
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-02
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: White Blood Cell Count Decreased, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Deep Vein Thrombosis, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Vincristine Sulfate
Dosage: 2 mg milligram(s), unknown, intravenous (not otherwise specified)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg milligram(s), 1 day, oral, 200 mg milligram(s), 1 day, oral
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Clozapine
Dosage: 200 mg milligram(s), 1 day, oral, 200 mg milligram(s), 1 day, oral
Administration route: Oral
Indication: Schizophrenia
Start date: 2011-12-02
Doxorubicin HCL
Dosage: 110 mg milligram(s), unknown, intravenous (not otherwise specified)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Neupogen
Dosage: 800 mg milligram(s), unknown, intravenous (not otherwise specified)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Cyclophosphamide
Dosage: 1600 milligram(s), unknown, intravenous (not otherwise specified)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Prednisolone
Dosage: 60 mg milligram(s), unknown, unknown
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Other drugs received by patient: Citalopram; Amisulpride; Pirenzepine
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-29
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Deep Vein Thrombosis, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clozapine
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-01-12
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma Stage II
Start date: 2011-11-22
Prednisolone
Indication: Diffuse Large B-Cell Lymphoma Stage II
Start date: 2011-11-22
Clozapine
Start date: 2011-12-02
Neupogen
Indication: Diffuse Large B-Cell Lymphoma Stage II
Start date: 2011-11-23
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma Stage II
Start date: 2011-11-22
Vincristine
Indication: Diffuse Large B-Cell Lymphoma Stage II
Start date: 2011-09-22
Other drugs received by patient: Pirenzepine; Amisulpride; Citalopram Hydrobromide
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-23
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: White Blood Cell Count Decreased, Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Neupogen
Dosage: 800 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Vincristine Sulfate
Dosage: 2 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Doxorubicin HCL
Dosage: 110 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Prednisolone
Dosage: 60 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Cyclophosphamide
Dosage: 1600 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Start date: 2011-12-02
Other drugs received by patient: Citalopram; Amisulpride; Pirenzepine
Possible Neupogen side effects in 88 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-23
Patient: 88 year old male
Reactions: White Blood Cell Count Decreased, Respiratory Distress
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Neupogen
Other drugs received by patient: Ativan; Pepcid; Solu-Cortef; Iron; Keppra; Synthroid; Folic Acid; Seroquel; Colymycin / 00013206 /; Plaquenil; Miralax / 00754501 /; Proscar; Haldol; Vitamin B6
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-22
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: Agranulocytosis, Neutropenia, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Prednisolone
Dosage: 60 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, bid
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Clozapine
Dosage: 200 mg, bid
Administration route: Oral
Start date: 2011-12-02
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Cyclophosphamide
Dosage: 1600 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Neupogen
Dosage: 800 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Possible Neupogen side effects in 42 year old male
Reported by a pharmacist from United Kingdom on 2012-02-21
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: White Blood Cell Count Decreased, Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Deep Vein Thrombosis, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 110 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, bid
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Neupogen
Dosage: 800 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Prednisolone
Dosage: 60 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, bid
Administration route: Oral
Start date: 2011-12-02
Vincristine
Dosage: 2 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Cyclophosphamide
Dosage: 1600 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Other drugs received by patient: Pirenzepine; Amisulpride; Citalopram Hydrobromide
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-30
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: Agranulocytosis, Neutropenia, Diffuse Large B-Cell Lymphoma, Leukopenia, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1600 mg milligram(s), intravenous (not otherwise specified)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Vincristine Sulfate
Dosage: 2 mg milligram(s) intravenous (not otherwise specified)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Prednisolone
Dosage: 60 mg milligram(s)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Neupogen
Dosage: 800 mg milligram(s), intravenous (not otherwise specified)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Clozapine
Dosage: 200 mg milligram(s), 1 day, oral
Administration route: Oral
Indication: Schizophrenia
Start date: 2011-12-02
Clozapine
Dosage: 200 mg milligram(s), 1 day, oral
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Doxorubicin HCL
Dosage: 110 mg milligram(s), intravenous (not otherwise specified)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Other drugs received by patient: (Pirenzeprine); (Citalopram); (Amisulpride)
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-26
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma Stage II
Start date: 2011-11-22
Prednisolone
Indication: Diffuse Large B-Cell Lymphoma Stage II
Start date: 2011-11-22
Neupogen
Indication: Diffuse Large B-Cell Lymphoma Stage II
Start date: 2011-11-23
Clozapine
Start date: 2011-12-02
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma Stage II
Start date: 2011-11-22
Vincristine
Indication: Diffuse Large B-Cell Lymphoma Stage II
Start date: 2011-09-22
Clozapine
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-01-12
Other drugs received by patient: Amisulpride; Citalopram Hydrobromide; Pirenzepine
Possible Neupogen side effects in 42 year old male
Reported by a pharmacist from United Kingdom on 2012-01-23
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: White Blood Cell Count Decreased, Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Prednisolone
Dosage: 60 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, bid
Administration route: Oral
Start date: 2011-12-02
Cyclophosphamide
Dosage: 1600 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Vincristine
Dosage: 2 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Doxorubicin HCL
Dosage: 110 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Neupogen
Dosage: 800 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Clozapine
Dosage: 200 mg, bid
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Other drugs received by patient: Citalopram; Amisulpride; Pirenzepine
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-20
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: Sepsis, Bone Marrow Failure, non-Hodgkin's Lymphoma, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1600 mg milligram(s), intravenous
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Neupogen
Dosage: 800 mg milligram(s)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Doxorubicin HCL
Dosage: 2 mg milligram(s), unknown intravenous
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg milligram(s), 1 day, oral
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Vincristine Sulfate
Dosage: 2 mg milligram(s), intravenous
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Prednisolone
Dosage: 60 mg milligram(s)
Indication: Diffuse Large B-Cell Lymphoma
Other drugs received by patient: Pirenzepine; Citalopram Hydrobromide; Amisulpride
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-20
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: Diffuse Large B-Cell Lymphoma Stage II, White Blood Cell Count Decreased, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 110 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Neupogen
Dosage: 800 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Cyclophosphamide
Dosage: 1600 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Vincristine Sulfate
Dosage: 2 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Prednisolone
Dosage: 60 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Start date: 2011-12-02
Other drugs received by patient: Citalopram; Amisulpride; Pirenzepine
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-20
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: Agranulocytosis, Neutropenia, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Neupogen
Dosage: 800 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Cyclophosphamide
Dosage: 1600 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, bid
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Clozapine
Dosage: 200 mg, bid
Administration route: Oral
Start date: 2011-12-02
Prednisolone
Dosage: 60 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-17
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: Agranulocytosis, Neutropenia, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clozapine
Dosage: 200 mg, bid
Administration route: Oral
Start date: 2011-12-02
Cyclophosphamide
Dosage: 1600 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Neupogen
Dosage: 800 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Prednisolone
Dosage: 60 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, bid
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-17
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: Diffuse Large B-Cell Lymphoma Stage II, White Blood Cell Count Decreased, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Cyclophosphamide
Dosage: 1600 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Vincristine Sulfate
Dosage: 2 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Doxorubicin HCL
Dosage: 110 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Start date: 2011-12-02
Neupogen
Dosage: 800 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Prednisolone
Dosage: 60 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Other drugs received by patient: Amisulpride; Pirenzepine; Citalopram
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-16
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: Diffuse Large B-Cell Lymphoma Stage II, White Blood Cell Count Decreased, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Deep Vein Thrombosis, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Neupogen
Dosage: 800 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Cyclophosphamide
Dosage: 1600 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Prednisolone
Dosage: 60 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Vincristine
Dosage: 2 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Doxorubicin HCL
Dosage: 110 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, bid
Administration route: Oral
Start date: 2011-12-02
Clozapine
Dosage: 200 mg, bid
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Other drugs received by patient: Amisulpride; Citalopram; Pirenzepine
Possible Neupogen side effects in 43 year old male
Reported by a physician from Netherlands on 2012-01-05
Patient: 43 year old male, weighing 78.0 kg (171.6 pounds)
Reactions: Embolism
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Rituximab
Dosage: 750 mg, unk
Indication: B-Cell Lymphoma
Start date: 2011-09-01
Vincristine
Dosage: 2 mg, unk
Indication: B-Cell Lymphoma
Start date: 2011-09-01
Neupogen
Dosage: 6 mg, unk
Indication: B-Cell Lymphoma
Start date: 2011-09-02
Prednisolone
Dosage: 10 mg, unk
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2011-09-01
Doxorubicin HCL
Dosage: 105 mg, unk
Indication: B-Cell Lymphoma
Start date: 2011-09-01
Cyclophosphamide
Dosage: 575 mg, unk
Indication: B-Cell Lymphoma
Start date: 2011-09-01
Vincristine
Dosage: 1 mg, unk
Possible Neupogen side effects in 42 year old male
Reported by a pharmacist from United Kingdom on 2012-01-04
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Prednisolone
Indication: Diffuse Large B-Cell Lymphoma Stage II
Start date: 2011-11-22
Neupogen
Indication: Diffuse Large B-Cell Lymphoma Stage II
Start date: 2011-11-23
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma Stage II
Start date: 2011-11-22
Clozapine
Start date: 2011-12-02
Vincristine
Indication: Diffuse Large B-Cell Lymphoma Stage II
Start date: 2011-09-22
Clozapine
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-01-12
Other drugs received by patient: Pirenzepine; Amisulpride; Citalopram
Page 1 Next >>
|